Caricamento...
4CPS-162 Infliximab serum concentrations, antibody formation and clinical response in psoriatic patients
BACKGROUND: A large variability in biopharmaceutical kinetics exists between patients and even within a patient over time. Also, adequate thorough concentrations are linked to response in psoriasis. Therapeutic drug monitoring of biopharmaceuticals (i.e. infliximab–IFX) together with clinical respon...
Salvato in:
| Pubblicato in: | Eur J Hosp Pharm |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Group
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535484/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.253 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|